PAR 5.00% 21.0¢ paradigm biopharmaceuticals limited..

How would involvement from a Venture capitalists or Private equity group look for Paradigm, page-43

  1. 658 Posts.
    lightbulb Created with Sketch. 277
    Mozz, I get it that you want to believe and you want to hope that there is a solution, but I find your hopium needs some reality check from time to time.
    I am not sure where this forward sell of royalty 1st began getting airtime (was it @farmerbob?), but it has to stop.

    Clearside, used actual collateral to secure that funding. What collateral you ask, well it was their 1st approved commercial product (Xipere). So 1 products sales revenues supports the development / study of another, all very normal, but PAR doesn't have any of that collateral.
    The people at Healthcare Royalty have a due diligence process and part of that screening is NOT investing in a product that has not completed phase 3 development.
    How do I know this? Well the good people at HCR were kind enough to give me 20 minutes of their time this morning for a conference call.

    I will let you all know what the people at LaunchTx have to say about their process, post that call next week.





 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
21.0¢
Change
0.010(5.00%)
Mkt cap ! $73.48M
Open High Low Value Volume
22.5¢ 23.5¢ 20.0¢ $1.067M 4.986M

Buyers (Bids)

No. Vol. Price($)
1 1519 20.5¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 59999 2
View Market Depth
Last trade - 16.10pm 31/10/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.